ABGABEVENTIL
European patent · EP4493477 · In force
Register entry
- Publication number
- EP4493477
- Application number
- EP22940456
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 28, 2022
- Published
- Jan 22, 2025
- Granted
- Jul 1, 2026
- Protection ends at the latest
- Apr 27, 2042
- Next annual fee due
- Apr 30, 2027
- IPC classes
- B65D 5/72 (2006.01)B65D 47/10 (2006.01)B65D 47/08 (2006.01)B65D 47/20 (2006.01)
- PCT application
- PCT/US2022/026725 28.04.2022
- PCT publication
- WO2023/211448 02.11.2023
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 01.07.2026
Parties
Inventor
GAUS, David, J.
Crystal Lake, IL 60014-9695, US
OLECHOWSKI, Gregory, M.
Crystal Lake, IL 60014-9695, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.